One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation, Blood. avr, vol.49, issue.4, pp.511-544, 1977. ,
Graft--versus--leukemia reactions after bone marrow transplantation, Blood. 1 févr, vol.75, issue.3, pp.555-62, 1990. ,
Hematopoietic stem--cell transplantation, N Engl J Med. 27 avr, vol.354, issue.17, pp.1813-1839, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00849640
Recovery from radiation injury. Science. 4 mai, vol.113, pp.510-511, 1951. ,
A direct measurement of the radiation sensitivity of normal mouse bone marrow cells, Radiat Res. août, vol.178, issue.2, pp.3-7, 1961. ,
Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells, Nature. 2 févr, vol.197, pp.452-456, 1963. ,
THE DISTRIBUTION OF COLONY--FORMING CELLS AMONG SPLEEN COLONIES, J Cell Comp Physiol. déc, vol.62, pp.327-363, 1963. ,
DECLINE IN COLONY--FORMING ABILITY OF MARROW CELLS SUBJECTED TO SERIAL TRANSPLANTATION INTO IRRADIATED MICE, J Cell Comp Physiol. août, vol.64, pp.23-31, 1964. ,
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature. 17 févr, vol.367, issue.6464, pp.645-653, 1994. ,
Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2R?c--deficient mice, J Clin Invest, vol.121, issue.1, pp.384-95, 2011. ,
Identical nature of the leucocyte antigens detectable in monozygotic twins by means of immune iso--leuco--agglutinins, Nature. 21 déc, vol.180, issue.4599, p.1430, 1957. ,
The major histocompatibility complex in man, Science. 25 sept, vol.213, issue.4515, pp.1469-74, 1981. ,
, Immunologie fondamentale et immunopathologie: enseignements thématique et intégré : tissu lymphoïde et sanguin, immunopathologie et immuno--intervention, 2018.
Antileukemic effect of chronic graft--versus--host disease: contribution to improved survival after allogeneic marrow transplantation, N Engl J Med, vol.18, issue.25, pp.1529-1562, 1981. ,
CD8(+) minor histocompatibility antigen--specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells, Proc Natl Acad Sci, vol.96, issue.15, pp.8639-8683, 1999. ,
The DBY gene codes for an HLA--DQ5--restricted human male--specific minor histocompatibility antigen involved in graft--versus--host disease, Blood. 15 avr, vol.99, issue.8, pp.3027-3059, 2002. ,
Molecules and mechanisms of the graft--versus--leukaemia effect, Nat Rev Cancer. mai, vol.4, issue.5, pp.371-80, 2004. ,
HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA--A, --B, --C, --DRB1, or --DQB1 is strongly associated with overall survival, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. août, vol.13, issue.8, pp.965-74, 2007. ,
Mismatches of minor histocompatibility antigens between HLA--identical donors and recipients and the development of graft--versus--host disease after bone marrow transplantation, N Engl J Med. 1 févr, vol.334, issue.5, pp.281-286, 1996. ,
Minor histocompatibility antigens in human stem cell transplantation, Exp Hematol. sept, vol.31, issue.9, pp.743-51, 2003. ,
Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells, Immunol Today. sept, vol.16, issue.9, pp.437-477, 1995. ,
Haploidentical hematopoietic transplantation: current status and future perspectives, Blood. 1 déc, vol.118, issue.23, pp.6006-6023, 2011. ,
Defining the intensity of conditioning regimens: working definitions, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. déc, vol.15, issue.12, pp.1628-1661, 2009. ,
Who is fit for allogeneic transplantation? Blood. 2 déc, vol.116, pp.4762-70, 2010. ,
Standard graft--versus--host disease prophylaxis with or without anti--T--cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open--label, multicentre phase 3 trial, Lancet Oncol. sept, vol.10, issue.9, pp.855-64, 2009. ,
Antilymphocyte Globulin for Prevention of Chronic Graft--versus--Host Disease, N Engl J Med. 7 janv, vol.374, issue.1, pp.43-53, 2016. ,
,
, Schweiz Med Wochenschr. 12 déc, vol.111, issue.50, pp.1975-1982, 1981.
Cyclosporine as prophylaxis for graft--versus--host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia, Blood. juin, vol.65, issue.6, pp.1325-1359, 1985. ,
,
, Pathol Biol (Paris). août, vol.62, issue.4, pp.197-203, 2014.
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia, N Engl J Med. 20 mars, vol.314, issue.12, pp.729-764, 1986. ,
Mycophenolate mofetil versus methotrexate for prevention of graft--versus--host disease in people receiving allogeneic hematopoietic stem cell transplantation. Cochrane Haematological Malignancies Group, éditeur. Cochrane Database Syst Rev ,
,
Mycophenolate mofetil vs. methotrexate for the prevention of graft--versus--host--disease----systematic review and meta--analysis, Leuk Res. mars, vol.38, issue.3, pp.352-60, 2014. ,
Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood, vol.98, pp.2900-2908, 2001. ,
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program, Blood. 3 janv, vol.121, issue.1, pp.197-206, 2013. ,
The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. sept, vol.14, issue.9, pp.2-7, 2008. ,
Allogeneic marrow stem--cell transplantation from human leukocyte antigen--identical siblings versus human leukocyte antigen--allelic--matched unrelated donors (10/10) in patients with standard--risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy, J Clin Oncol Off J Am Soc Clin Oncol. 20 déc, vol.24, issue.36, pp.5695-702, 2006. ,
Comparable survival after HLA--well--matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood. 16 sept, vol.116, pp.1839-1887, 2010. ,
Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells, Proc Natl Acad Sci, vol.86, issue.10, pp.3828-3860, 1989. ,
Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical--cord blood from an HLA--identical sibling, N Engl J Med, vol.321, issue.17, pp.1174-1182, 1989. ,
Treatment of high--risk acute leukemia with T--cell--depleted stem cells from related donors with one fully mismatched HLA haplotype, N Engl J Med, vol.339, issue.17, pp.1186-93, 1998. ,
Durable engraftment of major histocompatibility complex--incompatible cells after nonmyeloablative conditioning with fludarabine, low--dose total body irradiation, and posttransplantation cyclophosphamide, Blood. 1 déc, vol.98, issue.12, pp.3456-64, 2001. ,
HLA--haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high--dose, posttransplantation cyclophosphamide, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. juin, vol.14, issue.6, pp.641-50, 2008. ,
Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide, Sci Transl Med, vol.5, issue.211, pp.211-157, 2013. ,
Assessment of aldehyde dehydrogenase in viable cells, Blood. 15 mai, vol.85, issue.10, pp.2742-2748, 1995. ,
Haploidentical T Cell--Replete Transplantation with Post--Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen--Matched Related or Unrelated Donor, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. janv, vol.22, issue.1, pp.119-143, 2016. ,
Comparison of outcomes following transplantation with T--replete HLA--haploidentical donors using post--transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or older, Bone Marrow Transplant. juin, vol.53, issue.6, pp.756-63, 2018. ,
T--cell--replete HLA--haploidentical hematopoietic transplantation for hematologic malignancies using post--transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA--matched related and unrelated donor transplantation, J Clin Oncol Off J Am Soc Clin Oncol. 1 avr, vol.31, issue.10, pp.1310-1316, 2013. ,
Reduced--Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA--Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis, J Clin Oncol Off J Am Soc Clin Oncol. 10 sept, vol.34, issue.26, pp.3141-3150, 2016. ,
Post--Transplantation Cyclophosphamide--Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation, J Clin Oncol, vol.35, issue.30, pp.3425-3457, 2017. ,
Comparable composite endpoints after HLA--matched and HLA--haploidentical transplantation with post--transplantation cyclophosphamide, Haematologica. févr, vol.102, issue.2, pp.391-400, 2017. ,
Sequential Conditioning with Thiotepa in T Cell--Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo--Mismatched, and Unrelated Donors, Biol Blood Marrow Transplant. mai, vol.24, issue.5, pp.1013-1034, 2018. ,
HLA--Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single--Center Donor Comparison, Biol Blood Marrow Transplant. juill, vol.24, issue.7, pp.1449-54, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02143551
Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Cancer, 2019. ,
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia, Blood. 20 août, vol.126, issue.8, pp.1033-1073, 2015. ,
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA--mismatched related bone marrow or unrelated double umbilical cord blood grafts, Blood. 14 juill, vol.118, issue.2, pp.282-290, 2011. ,
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia, Leukemia. sept, vol.29, issue.9, pp.1891-900, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02007180
Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT--Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine, J Hematol OncolJ Hematol Oncol. déc, vol.11, issue.1, p.110, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02143659
Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist, Blood. 17 juill, vol.124, issue.3, pp.334-377, 2014. ,
Reduced mortality after allogeneic hematopoietic--cell transplantation, N Engl J Med, vol.363, issue.22, pp.2091-101, 2010. ,
The biology of graft--versus--host reactions, Harvey Lect, vol.62, pp.21-78, 19671966. ,
Acute graft--versus--host disease: from the bench to the bedside, Blood, vol.12, issue.20, pp.4327-4363, 2009. ,
Clinical manifestations of graft--versus--host disease in human recipients of marrow from HL--A--matched sibling donors, Transplantation. oct, vol.18, issue.4, pp.295-304, 1974. ,
A retrospective analysis of therapy for acute graft--versus--host disease: initial treatment, Blood, vol.76, issue.8, pp.1464-72, 1990. ,
Chronic graft--versus--host disease and other late complications of bone marrow transplantation, Semin Hematol. juill, vol.28, issue.3, pp.250-259, 1991. ,
Multicenter Standardization of Acute Graft--versus--Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. janv, vol.22, issue.1, pp.4-10, 2016. ,
EBMT--NIH--CIBMTR Task Force position statement on standardized terminology & guidance for graft--versus--host disease assessment, Bone Marrow Transplant, vol.53, issue.11, pp.1401-1416, 2018. ,
Graft--versus--host disease, Lancet Lond Engl. 2 mai, vol.373, issue.9674, pp.1550-61, 2009. ,
Prophylaxis and management of graft versus host disease after stem--cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation, Lancet Haematol. févr, vol.7, issue.2, pp.157-67, 2020. ,
Current issues in chronic graft--versus--host disease, Blood. 17 juill, vol.124, issue.3, pp.374-84, 2014. ,
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft--versus--Host Disease: I. The 2014 Diagnosis and Staging Working Group report, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. mars, vol.21, issue.3, pp.389-401, 2015. ,
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, vol.15, issue.10, pp.1143-238, 2009. ,
Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, Intern Med J. déc, vol.44, issue.12b, pp.1333-1382, 2014. ,
Management of Epstein--Barr Virus infections and post--transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation, Sixth European Conference on Infections in Leukemia, vol.101, pp.803-814, 2016. ,
How to manage EBV reactivation and EBV--PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A ,
, Bull Cancer (Paris). déc, vol.104, issue.12S, pp.181-188, 2017.
Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors, Hepatol Baltim Md. févr, vol.4, issue.1, pp.116-138, 1984. ,
Venoocclusive disease of the liver following bone marrow transplantation, Transplantation. déc, vol.44, issue.6, pp.778-83, 1987. ,
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno--occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation, Bone Marrow Transplant. juill, vol.51, issue.7, pp.906-918, 2016. ,
Sinusoidal obstruction syndrome (hepatic veno--occlusive disease), J Clin Exp Hepatol. déc, vol.4, issue.4, pp.332-378, 2014. ,
Phase 3 trial of defibrotide for the treatment of severe veno--occlusive disease and multi--organ failure, Blood. 31 mars, vol.127, issue.13, pp.1656-65, 2016. ,
Post--bone marrow transplant thrombotic microangiopathy, Bone Marrow Transplant. juill, vol.51, issue.7, pp.891-898, 2016. ,
Haemolytic uraemic syndrome, Lancet Lond Engl. 12 août, vol.390, pp.681-96, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02155934
Hematopoietic stem cell transplant--associated thrombotic microangiopathy: current paradigm and novel therapies, Bone Marrow Transplant, vol.53, issue.2, pp.129-166, 2018. ,
A new paradigm: Diagnosis and management of HSCT--associated thrombotic microangiopathy as multi--system endothelial injury, Blood Rev. mai, vol.29, issue.3, pp.191-204, 2015. ,
Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis, Clin J Am Soc Nephrol CJASN. févr, vol.4, issue.2, pp.345-53, 2009. ,
Hematopoietic stem cell transplant--associated thrombotic microangiopathy: review of pharmacologic treatment options. Transfusion (Paris), févr, vol.55, issue.2, pp.452-460, 2015. ,
Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant--Associated Thrombotic Microangiopathy: A Study From the SFGM--TC, Transplantation. sept, vol.99, issue.9, pp.1953-1962, 2015. ,
Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced--intensity conditioning, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. juin, vol.20, issue.6, pp.890-895, 2014. ,
Risk--stratified outcomes of nonmyeloablative HLA--haploidentical BMT with high--dose posttransplantation cyclophosphamide, Blood. 7 mai, vol.125, issue.19, pp.3024-3055, 2015. ,
Longer delay of hematological recovery and increased transfusion needs after haploidentical compared to non--haploidentical stem cell transplantation, Bone Marrow Transplant. août, vol.51, issue.8, pp.1150-1152, 2016. ,
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T--Cell-Replete Haploidentical Donor Transplantation Using Post--Transplant Cyclophosphamide, J Clin Oncol, vol.35, issue.26, pp.3002-3011, 2017. ,
Haploidentical Hematopoietic Cell Transplant with Post--Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, vol.23, issue.10, pp.1736-1779, 2017. ,
Cancer statistics, Cancer Statistics, vol.66, pp.7-30, 2016. ,
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft--versus--host disease: I. Diagnosis and staging working group report, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. déc, vol.11, issue.12, pp.945-56, 2005. ,
Platelet and Red Blood Cell Utilization and Transfusion Independence in Umbilical Cord Blood and Allogeneic Peripheral Blood Hematopoietic Cell Transplants, Biol Blood Marrow Transplant. mai, vol.17, issue.5, pp.710-716, 2011. ,
Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced--intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood, Haematologica. févr, vol.99, issue.2, pp.370-377, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01325615
Impact of HLA disparity in the graft--versus--host direction on engraftment in adult patients receiving reduced--intensity cord blood transplantation, Blood. 20 août, vol.114, issue.8, pp.1689-95, 2009. ,
Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. mai, vol.21, issue.5, pp.889-93, 2015. ,
Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation, Biol Blood Marrow Transplant. avr, vol.24, issue.4, pp.708-724, 2018. ,
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors, Blood. 15 déc, vol.100, issue.13, pp.4358-66, 2002. ,
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, vol.8, issue.9, pp.512-532, 2002. ,
Iron overload in allogeneic hematopoietic stem cell transplant recipients, Arch Pathol Lab Med. mai, vol.136, issue.5, pp.532-540, 2012. ,
The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation, Transfusion (Paris). avr, vol.54, issue.4, pp.1071-80, 2014. ,
Transfusion--related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, Transfusion (Paris). avr, vol.55, issue.4, pp.709-727, 2010. ,
Red blood cell transfusion burden by day 30 predicts mortality in adults after single--unit cord blood transplantation, Bone Marrow Transplant, vol.54, issue.11, pp.1836-1882, 2019. ,
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft--versus--Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, vol.24, issue.5, pp.973-82, 2018. ,
Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft--versus--host disease, donor type, cytomegalovirus infections and cell dose, Br J Haematol. janv, vol.112, issue.1, pp.219-246, 2001. ,
Blood transfusion in marrow graft recipients, Ann Hematol. août, vol.65, issue.2, pp.66-70, 1992. ,
Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant, Bone Marrow Transplant. févr, vol.33, issue.4, pp.419-442, 2004. ,
Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk. Transfusion (Paris), mars, vol.50, issue.3, pp.649-55, 2010. ,
dihydroxy--2--propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro, Antimicrob Agents Chemother. mars, vol.9, issue.1, pp.452-456, 1987. ,
Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre--emptive therapy: a retrospective cohort study, Lancet Haematol. mars, vol.3, issue.3, pp.119-127, 2016. ,
Cytomegalovirus in hematopoietic stem cell transplant recipients --management of infection, Expert Rev Hematol, vol.9, issue.11, pp.1093-105, 2016. ,
Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation, Exp Hematol. janv, vol.38, issue.1, pp.55-60, 2010. ,
Association of an Impaired Bone Marrow Microenvironment with Secondary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation, Biol Blood Marrow Transplant. oct, vol.19, issue.10, pp.1465-73, 2013. ,
The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation, Ann Hematol, vol.94, issue.10, pp.1699-705, 2015. ,
Donor--specific anti--human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets, J Hematol OncolJ Hematol Oncol, vol.8, issue.1, p.84, 2015. ,
The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function, Bone Marrow Transplant. févr, vol.51, issue.2, pp.249-55, 2016. ,
Early and late graft--failure after transplants, Bone Marrow Transplant. févr, vol.51, issue.2, pp.182-185, 2016. ,
Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation, Bone Marrow Transplant. déc, vol.50, issue.12, pp.1574-1581, 2015. ,
Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation, Biol Blood Marrow Transplant. mai, vol.22, issue.5, pp.919-943, 2016. ,
Donor--Specific Anti--Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation, J Immunol Res, vol.2017, pp.1-8, 2017. ,
CD34(+) immunoselected cells for poor graft function following allogeneic BMT, Cytotherapy, vol.2, issue.5, pp.367-70, 2000. ,
Boost of CD34+--selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation, Haematologica. juill, vol.91, issue.7, pp.935-975, 2006. ,
Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34--selected cells infused without conditioning, Bone Marrow Transplant. mai, vol.49, issue.5, pp.720-721, 2014. ,
CD34(+)--selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. mars, vol.20, issue.3, pp.382-388, 2014. ,
Poor graft function can be durably and safely improved by CD34+--selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation, J Cancer Res Clin Oncol. déc, vol.141, issue.12, pp.2241-51, 2015. ,
Fresh or Cryopreserved CD34 + --Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplantation, Biol Blood Marrow Transplant. juill, vol.23, issue.7, pp.1072-1079, 2017. ,
,
, /01234564789+:+;(-+:+61<864=><+?7@1+!796A5BB7C1<DD<E+FGH+:+I78I<8612+J<+CB70@B<9+17@C<9E+48J2!+:+ 48J2!<8J58I<E+FK+:+I78I<8612+J<+!B5L@<66<9+JM5!N21=9<+7@+>2B58C<+J<+I78I<8612+J<+ !B5L@<66<9E+KOO+:+!7BP8@IB541<9+8<@617!N4B<9
, /012034 56#5 -#6), vol.698, pp.56-62
, $30#$45!6 -<=>(?(FGH'4 56"* -#6)
, , vol.20, pp.69-78
, #, issue.7, pp.56-60
,
, 5#74 #5:98 %&' (
, ?@A<4 #59) -#57)(6(D5#74 #5E) #5:: -#5"#, vol.84, p.5
, , vol.45
,
, 5#84 #5#89, #E, vol.5, issue.6, pp.8-13
,
, @C(0@31
,
, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux. Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte
, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences
, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire
, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément. Je préserverai l'indépendance nécessaire à l'accomplissement de ma mission
, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité
, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses
, que je sois déshonoré et méprisé si j'y manque